Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Farfetch (FTCH) Stock Trades Down, Here Is Why
Post Content Post Views: 141
Nvidia delays rollout of new custom-made AI chip for China, shares dip
Post Content Post Views: 137
Coinbase CEO says crypto industry can turn the page after historic Binance settlement
The crypto industry can close the chapter on a litany of scandals after Binance was hit with a historic settlement, Coinbase CEO Brian Armstrong told CNBC. Post Views: 128
German export sentiment improves in November – Ifo
Post Content Post Views: 125
BMO Discount Bond Index ETF declares CAD 0.03 dividend
Post Content Post Views: 143
Medicure GAAP EPS of C$0.01, revenue of C$5M
Post Content Post Views: 140